304 related articles for article (PubMed ID: 3760783)
1. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Studies on C9 binding and incorporation into high molecular weight complexes.
Rosenfeld SI; Jenkins DE; Leddy JP
J Exp Med; 1986 Oct; 164(4):981-97. PubMed ID: 3760783
[TBL] [Abstract][Full Text] [Related]
2. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
[TBL] [Abstract][Full Text] [Related]
3. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.
Parker CJ; Wiedmer T; Sims PJ; Rosse WF
J Clin Invest; 1985 Jun; 75(6):2074-84. PubMed ID: 4008653
[TBL] [Abstract][Full Text] [Related]
5. Enhanced complement-mediated lysis of type III paroxysmal nocturnal hemoglobinuria erythrocytes involves increased C9 binding and polymerization.
Hu VW; Nicholson-Weller A
Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5520-4. PubMed ID: 3860874
[TBL] [Abstract][Full Text] [Related]
6. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
Hänsch GM; Schönermark S; Roelcke D
J Clin Invest; 1987 Jul; 80(1):7-12. PubMed ID: 3597779
[TBL] [Abstract][Full Text] [Related]
7. Restriction of cell lysis by homologous complement: I. An analysis of membrane attack complex formation on target membranes.
Houle JJ; Hoffmann EM; Esser AF
Blood; 1988 Feb; 71(2):280-6. PubMed ID: 3337896
[TBL] [Abstract][Full Text] [Related]
8. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
Sims PJ
Biochim Biophys Acta; 1983 Aug; 732(3):541-52. PubMed ID: 6871214
[TBL] [Abstract][Full Text] [Related]
9. Complement lysis of human erythrocytes. II. A unique interaction of human C8 and C9 with paroxysmal nocturnal hemoglobinuria erythrocytes.
Packman CH; Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1980 Jun; 124(6):2818-23. PubMed ID: 7189536
[No Abstract] [Full Text] [Related]
10. Characterization of the enhanced susceptibility of paroxysmal nocturnal hemoglobinuria erythrocytes to complement-mediated hemolysis initiated by cobra venom factor.
Parker CJ; Stone OL; Bernshaw NJ
J Immunol; 1989 Jan; 142(1):208-16. PubMed ID: 2909615
[TBL] [Abstract][Full Text] [Related]
11. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
[TBL] [Abstract][Full Text] [Related]
12. Differences in the terminal steps of complement lysis of normal and paroxysmal nocturnal hemoglobinuria red cells.
Rouault TA; Rosse WF; Bell S; Shelburne J
Blood; 1978 Feb; 51(2):325-30. PubMed ID: 620087
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.
Logue GL; Rosse WF; Adams JP
J Clin Invest; 1973 May; 52(5):1129-37. PubMed ID: 4700488
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.
Rosenfeld SI; Packman CH; Leddy JP
J Clin Invest; 1983 Apr; 71(4):795-808. PubMed ID: 6403580
[TBL] [Abstract][Full Text] [Related]
15. Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cells.
Rosenfeld SI; Packman CH; Jenkins DE; Countryman JK; Leddy JP
J Immunol; 1980 Nov; 125(5):2063-8. PubMed ID: 6776186
[No Abstract] [Full Text] [Related]
16. Determination of the number of lytic sites in biconcave and spheroid erythrocyte ghosts after complement lysis.
Bauer J; Podack ER; Valet G
J Immunol; 1979 May; 122(5):2032-6. PubMed ID: 448115
[No Abstract] [Full Text] [Related]
17. Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.
Zalman LS; Wood LM; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6975-9. PubMed ID: 2428045
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of complement-mediated lysis of dithiothreitol-treated erythrocytes involves increased C9 insertion and polymerization.
Hu VW; Mazorow DL; Nicholson-Weller A; Shin ML
Mol Immunol; 1987 Aug; 24(8):887-96. PubMed ID: 2821389
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.
Holguin MH; Fredrick LR; Bernshaw NJ; Wilcox LA; Parker CJ
J Clin Invest; 1989 Jul; 84(1):7-17. PubMed ID: 2738160
[TBL] [Abstract][Full Text] [Related]
20. Interactions of complement with the red-cell membrane.
Rosse WF
Semin Hematol; 1979 Apr; 16(2):128-39. PubMed ID: 384519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
